{"database": "open_comments", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and document_type = \"Notice\" sorted by comment_end_date descending", "rows": [["FDA-2026-N-0131-0001", "FDA", "FDA-2026-N-0131", "FDA Rare Disease Innovation Hub Future Programming; Request for Comments", "Notice", "Request for Comments", "2026-01-30", 2026, 1, "2026-01-30", "2027-01-01", "2026-05-05 09:00:20", "2026-01903", 1, 0, "09000064b91893ee"], ["FDA-2016-D-1280-0005", "FDA", "FDA-2016-D-1280", "Electronic Submission of Postmarketing Individual Case Safety Reports to the Food and Drug Administration Adverse Event Monitoring System Using International\nCouncil of Harmonisation E2B(R3) Data Standards; Regional Data Elements and Implementation Schedule", "Notice", "Announcement", "2026-04-06", 2026, 4, "2026-04-06", "2026-10-02", "2026-04-07 09:00:25", "2026-06660", 1, 0, "09000064b9253dbc"], ["FDA-2025-E-2426-0006", "FDA", "FDA-2025-E-2426", "Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA", "Notice", "Determinations", "2026-02-13", 2026, 2, "2026-02-13", "2026-08-13", "2026-02-13 20:03:13", "2026-02901", 1, 0, "09000064b91aa6fb"], ["FDA-2025-E-0152-0006", "FDA", "FDA-2025-E-0152", "Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY", "Notice", "Determinations", "2026-02-06", 2026, 2, "2026-02-06", "2026-08-06", "2026-02-06 20:05:43", "2026-02388", 1, 0, "09000064b919467e"], ["FDA-2025-E-0153-0006", "FDA", "FDA-2025-E-0153", "Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY", "Notice", "Determinations", "2026-02-06", 2026, 2, "2026-02-06", "2026-08-06", "2026-02-06 20:06:34", "2026-02388", 1, 0, "09000064b919467f"], ["FDA-2024-E-3539-0006", "FDA", "FDA-2024-E-3539", "Determination of Regulatory Review Period for Purposes of Patent Extension; BEQVEZ", "Notice", "Determinations", "2026-02-06", 2026, 2, "2026-02-06", "2026-08-06", "2026-02-14 13:19:52", "2026-02387", 1, 0, "09000064b9195b4d"], ["FDA-2025-E-0154-0006", "FDA", "FDA-2025-E-0154", "Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY", "Notice", "Determinations", "2026-02-06", 2026, 2, "2026-02-06", "2026-08-06", "2026-02-06 20:07:01", "2026-02388", 1, 0, "09000064b9195c17"], ["FDA-2026-N-3273-0001", "FDA", "FDA-2026-N-3273", "Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments", "Notice", "Request for Comments", "2026-04-15", 2026, 4, "2026-04-15", "2026-07-24", "2026-04-15 17:05:22", "2026-07248", 1, 0, "09000064b9282224"], ["FDA-2025-N-6895-0001", "FDA", "FDA-2025-N-6895", "Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments\u2014Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List", "Notice", "Request for Comments", "2026-04-16", 2026, 4, "2026-04-16", "2026-07-23", "2026-05-17 09:00:23", "2026-07361", 1, 0, "09000064b92865ab"], ["FDA-2026-N-4126-0001", "FDA", "FDA-2026-N-4126", "Azodicarbonamide (ADA); Request for Information", "Notice", "Requests for Information (RFI)", "2026-05-13", 2026, 5, "2026-05-13", "2026-07-14", "2026-05-13 17:13:38", "2026-09508", 1, 0, "09000064b92d17fd"], ["FDA-2026-N-3098-0001", "FDA", "FDA-2026-N-3098", "Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting", "Notice", "60 Day Proposed Information Collection", "2026-05-13", 2026, 5, "2026-05-13", "2026-07-14", "2026-05-13 16:56:28", "2026-09543", 1, 0, "09000064b92d4966"], ["FDA-2026-N-2526-0001", "FDA", "FDA-2026-N-2526", "Butylated Hydroxytoluene (BHT); Request for Information", "Notice", "Requests for Information (RFI)", "2026-05-13", 2026, 5, "2026-05-13", "2026-07-14", "2026-05-13 17:01:00", "2026-09507", 1, 0, "09000064b92d4931"], ["FDA-2026-N-0005-0001", "FDA", "FDA-2026-N-0005", "Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information", "Notice", "Requests for Information (RFI)", "2026-05-13", 2026, 5, "2026-05-13", "2026-07-14", "2026-05-13 17:06:21", "2026-09533", 1, 0, "09000064b92d48f3"], ["FDA-2023-N-0119-0020", "FDA", "FDA-2023-N-0119", "Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for\nComments", "Notice", "Request for Comments", "2026-02-27", 2026, 2, "2026-02-27", "2026-07-11", "2026-04-14 09:00:18", "2026-03961", 1, 0, "09000064b91e326c"], ["FDA-2026-N-3070-0001", "FDA", "FDA-2026-N-3070", "Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey", "Notice", "60 Day Proposed Information Collection", "2026-05-04", 2026, 5, "2026-05-04", "2026-07-07", "2026-05-04 19:19:25", "2026-08604", 1, 0, "09000064b92c115c"], ["FDA-2018-N-3240-0377", "FDA", "FDA-2018-N-3240", "List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act", "Notice", "Request for Comments", "2026-05-01", 2026, 5, "2026-05-01", "2026-07-01", "2026-05-17 09:00:24", "2026-08552", 1, 0, "09000064b92bb724"], ["FDA-2026-N-3499-0001", "FDA", "FDA-2026-N-3499", "Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments", "Notice", "Request for Comments", "2026-05-01", 2026, 5, "2026-05-01", "2026-07-01", "2026-05-02 09:00:17", "2026-08521", 1, 0, "09000064b92bb7fb"], ["FDA-2026-N-3947-0001", "FDA", "FDA-2026-N-3947", "Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments", "Notice", "Request for Comments", "2026-05-01", 2026, 5, "2026-05-01", "2026-07-01", "2026-05-09 09:00:22", "2026-08524", 1, 0, "09000064b92bb6d7"], ["FDA-2026-N-4268-0001", "FDA", "FDA-2026-N-4268", "Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments", "Notice", "Request for Comments", "2026-05-01", 2026, 5, "2026-05-01", "2026-07-01", "2026-05-09 09:00:22", "2026-08499", 1, 0, "09000064b92bb7b3"], ["FDA-2026-N-3532-0001", "FDA", "FDA-2026-N-3532", "Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies", "Notice", "60 Day Proposed Information Collection", "2026-04-30", 2026, 4, "2026-04-30", "2026-06-30", "2026-05-02 09:00:17", "2026-08371", 1, 0, "09000064b92b7fb3"], ["FDA-2026-N-2366-0001", "FDA", "FDA-2026-N-2366", "Commissioner\u2019s National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments", "Notice", "Request for Comments", "2026-03-23", 2026, 3, "2026-03-23", "2026-06-30", "2026-05-01 09:00:14", "2026-05573", 1, 0, "09000064b922c21a"], ["FDA-2026-N-1321-0001", "FDA", "FDA-2026-N-1321", "ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing", "Notice", "Withdrawal", "2026-04-30", 2026, 4, "2026-04-30", "2026-06-30", "2026-05-16 09:00:16", "2026-08455", 1, 0, "09000064b92b7e81"], ["FDA-2026-N-2917-0001", "FDA", "FDA-2026-N-2917", "Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Clearance for Qualitative Data To Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and Feed", "Notice", "60 Day Proposed Information Collection", "2026-04-17", 2026, 4, "2026-04-17", "2026-06-17", "2026-04-17 16:47:09", "2026-07501", 1, 0, "09000064b9289353"], ["FDA-2026-N-3099-0001", "FDA", "FDA-2026-N-3099", "Agency Information Collection Activities; Proposed Collection; Comment Request; Radioactive Drug Research Committees", "Notice", "60 Day Proposed Information Collection", "2026-04-17", 2026, 4, "2026-04-17", "2026-06-17", "2026-04-17 16:55:18", "2026-07507", 1, 0, "09000064b9289303"], ["FDA-2025-E-0501-0006", "FDA", "FDA-2025-E-0501", "Determination of Regulatory Review Period for Purposes of Patent Extension; UNLOXCYT", "Notice", "Determinations", "2026-04-16", 2026, 4, "2026-04-16", "2026-06-16", "2026-04-16 17:49:56", "2026-07422", 1, 0, "09000064b928671f"], ["FDA-2025-E-0502-0006", "FDA", "FDA-2025-E-0502", "Determination of Regulatory Review Period for Purposes of Patent Extension; UNLOXCYT", "Notice", "Determinations", "2026-04-16", 2026, 4, "2026-04-16", "2026-06-16", "2026-04-16 17:53:26", "2026-07422", 1, 0, "09000064b9286364"], ["FDA-2026-N-3400-0001", "FDA", "FDA-2026-N-3400", "Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs", "Notice", "60 Day Proposed Information Collection", "2026-04-16", 2026, 4, "2026-04-16", "2026-06-16", "2026-04-18 09:00:22", "2026-07423", 1, 0, "09000064b9286561"], ["FDA-2026-N-3240-0001", "FDA", "FDA-2026-N-3240", "Agency Information Collection Activities; Proposed Collection; Comment Request; Importation of Prescription Drugs", "Notice", "60 Day Proposed Information Collection", "2026-04-16", 2026, 4, "2026-04-16", "2026-06-16", "2026-04-16 18:04:30", "2026-07421", 1, 0, "09000064b92866e7"], ["FDA-2025-N-1600-0003", "FDA", "FDA-2025-N-1600", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3", "Notice", "30 Day Proposed Information Collection", "2026-05-13", 2026, 5, "2026-05-13", "2026-06-13", "2026-05-13 17:17:21", "2026-09448", 1, 0, "09000064b92d4828"], ["FDA-2026-N-4492-0001", "FDA", "FDA-2026-N-4492", "Drug Repurposing for Unmet Medical Needs; Request for Information", "Notice", "Requests for Information (RFI)", "2026-05-12", 2026, 5, "2026-05-12", "2026-06-12", "2026-05-17 09:00:25", "2026-09366", 1, 0, "09000064b92d15f4"], ["FDA-2026-N-2742-0001", "FDA", "FDA-2026-N-2742", "Agency Information Collection Activities; Proposed Collection; Comment Request; Color Additive Certification", "Notice", "60 Day Proposed Information Collection", "2026-04-10", 2026, 4, "2026-04-10", "2026-06-10", "2026-04-10 18:01:37", "2026-06936", 1, 0, "09000064b926825a"], ["FDA-2026-N-2743-0001", "FDA", "FDA-2026-N-2743", "Agency Information Collection Activities; Proposed Collection; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503", "Notice", "60 Day Proposed Information Collection", "2026-04-10", 2026, 4, "2026-04-10", "2026-06-10", "2026-04-20 09:00:32", "2026-06935", 1, 0, "09000064b926821b"], ["FDA-2026-N-2915-0001", "FDA", "FDA-2026-N-2915", "Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Approval of Medical Devices", "Notice", "60 Day Proposed Information Collection", "2026-04-10", 2026, 4, "2026-04-10", "2026-06-10", "2026-04-10 17:47:50", "2026-06906", 1, 0, "09000064b9268328"], ["FDA-2026-N-2431-0001", "FDA", "FDA-2026-N-2431", "Agency Information Collection Activities; Proposed Collection; Comment Request; Administrative Practices and Procedures; Formal Hearings", "Notice", "60 Day Proposed Information Collection", "2026-04-07", 2026, 4, "2026-04-07", "2026-06-09", "2026-05-12 09:00:14", "2026-06719", 1, 0, "09000064b9255485"], ["FDA-2025-E-0863-0006", "FDA", "FDA-2025-E-0863", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:37:03", "2026-06478", 1, 0, "09000064b924cccb"], ["FDA-2025-E-0845-0006", "FDA", "FDA-2025-E-0845", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:34:01", "2026-06478", 1, 0, "09000064b924dac3"], ["FDA-2025-E-0866-0006", "FDA", "FDA-2025-E-0866", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:42:13", "2026-06478", 1, 0, "09000064b924ccce"], ["FDA-2025-E-0372-0005", "FDA", "FDA-2025-E-0372", "Determination of Regulatory Review Period for Purposes of Patent Extension; ZIIHERA", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:52:42", "2026-06476", 1, 0, "09000064b924da88"], ["FDA-2025-E-3074-0006", "FDA", "FDA-2025-E-3074", "Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:57:30", "2026-06480", 1, 0, "09000064b924c470"], ["FDA-2025-E-0871-0006", "FDA", "FDA-2025-E-0871", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:49:10", "2026-06478", 1, 0, "09000064b924c46e"], ["FDA-2025-E-3073-0006", "FDA", "FDA-2025-E-3073", "Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:55:54", "2026-06480", 1, 0, "09000064b924da86"], ["FDA-2025-E-3626-0006", "FDA", "FDA-2025-E-3626", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENFLONSIA", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:59:57", "2026-06479", 1, 0, "09000064b924d98d"], ["FDA-2025-E-0870-0006", "FDA", "FDA-2025-E-0870", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:48:07", "2026-06478", 1, 0, "09000064b924c46d"], ["FDA-2026-N-2740-0001", "FDA", "FDA-2026-N-2740", "Agency Information Collection Activities; Proposed Collection; Comment Request; Customer/Partner Customer Service Satisfaction Surveys", "Notice", "60 Day Proposed Information Collection", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:29:44", "2026-06482", 1, 0, "09000064b924dac4"], ["FDA-2025-E-0868-0006", "FDA", "FDA-2025-E-0868", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:44:23", "2026-06478", 1, 0, "09000064b924c0e1"], ["FDA-2025-E-0865-0006", "FDA", "FDA-2025-E-0865", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:39:45", "2026-06478", 1, 0, "09000064b924cccd"], ["FDA-2025-E-1672-0007", "FDA", "FDA-2025-E-1672", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENCELTO", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 18:06:28", "2026-06477", 1, 0, "09000064b924d940"], ["FDA-2014-E-2328-0006", "FDA", "FDA-2014-E-2328", "Determination of Regulatory Review Period for Purposes of Patent Extension; INJECTAFER", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 18:09:13", "2026-06483", 1, 0, "09000064b924d4f5"], ["FDA-2025-E-0864-0006", "FDA", "FDA-2025-E-0864", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:38:27", "2026-06478", 1, 0, "09000064b924cccc"], ["FDA-2025-E-0872-0006", "FDA", "FDA-2025-E-0872", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:50:02", "2026-06478", 1, 0, "09000064b924c46f"], ["FDA-2025-E-0158-0006", "FDA", "FDA-2025-E-0158", "Determination of Regulatory Review Period for Purposes of Patent Extension; HYMPAVZI", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 18:04:00", "2026-06481", 1, 0, "09000064b924d942"], ["FDA-2025-E-0867-0006", "FDA", "FDA-2025-E-0867", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:43:31", "2026-06478", 1, 0, "09000064b924c0e0"], ["FDA-2025-E-0869-0006", "FDA", "FDA-2025-E-0869", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:45:32", "2026-06478", 1, 0, "09000064b924ba07"], ["FDA-2026-N-0499-0002", "FDA", "FDA-2026-N-0499", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice", "Notice", "30 Day Proposed Information Collection", "2026-04-30", 2026, 4, "2026-04-30", "2026-06-02", "2026-04-30 17:46:42", "2026-08417", 1, 0, "09000064b92b80f2"], ["FDA-2026-N-0809-0001", "FDA", "FDA-2026-N-0809", "Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments", "Notice", "Request for Comments", "2026-03-03", 2026, 3, "2026-03-03", "2026-06-02", "2026-05-07 09:00:19", "2026-04196", 1, 0, "09000064b91ed501"], ["FDA-2026-N-2476-0001", "FDA", "FDA-2026-N-2476", "Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products;\nRequest for Information and Comments", "Notice", "Request for Comments", "2026-03-31", 2026, 3, "2026-03-31", "2026-06-02", "2026-05-17 09:00:21", "2026-06184", 1, 0, "09000064b92439d6"], ["FDA-2026-N-4390-0001", "FDA", "FDA-2026-N-4390", "AI-Enabled Optimization of Early- Phase Clinical Trials Pilot Program; Request for Information", "Notice", "Requests for Information (RFI)", "2026-04-29", 2026, 4, "2026-04-29", "2026-05-30", "2026-05-17 09:00:24", "2026-08281", 1, 0, "09000064b92b54c8"], ["FDA-2026-N-3962-0001", "FDA", "FDA-2026-N-3962", "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments\u2014\nUnited States (U.S.) 2026\u20132027 Formula for COVID\u201319 Vaccine Composition", "Notice", "Request for Comments", "2026-04-27", 2026, 4, "2026-04-27", "2026-05-28", "2026-05-17 09:00:24", "2026-08122", 1, 0, "09000064b92ad21d"], ["FDA-2026-N-2642-0001", "FDA", "FDA-2026-N-2642", "Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List Additions and Request for Comments", "Notice", "Request for Comments", "2026-04-23", 2026, 4, "2026-04-23", "2026-05-27", "2026-05-16 09:00:16", "2026-07910", 1, 0, "09000064b92a4e3b"], ["FDA-2024-E-5140-0006", "FDA", "FDA-2024-E-5140", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM", "Notice", "Determinations", "2025-11-24", 2025, 11, "2025-11-24", "2026-05-27", "2026-01-24 13:16:48", "2025-20667", 1, 0, "09000064b908e3f0"], ["FDA-2024-E-5139-0006", "FDA", "FDA-2024-E-5139", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM", "Notice", "Determinations", "2025-11-24", 2025, 11, "2025-11-24", "2026-05-27", "2026-01-24 13:16:48", "2025-20667", 1, 0, "09000064b908e3ef"], ["FDA-2024-E-5141-0006", "FDA", "FDA-2024-E-5141", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM", "Notice", "Determinations", "2025-11-24", 2025, 11, "2025-11-24", "2026-05-27", "2026-01-24 13:16:50", "2025-20667", 1, 0, "09000064b9092f99"], ["FDA-2024-E-5681-0006", "FDA", "FDA-2024-E-5681", "Determination of Regulatory Review Period for Purposes of Patent Extension; ALTIUS DIRECT ELECTRICAL NERVE STIMULATION\nSYSTEM", "Notice", "Determinations", "2025-11-24", 2025, 11, "2025-11-24", "2026-05-27", "2025-11-24 19:32:14", "2025-20668", 1, 0, "09000064b9093521"], ["FDA-2026-N-2365-0001", "FDA", "FDA-2026-N-2365", "Agency Information Collection Activities; Proposed Collection; Comment Request; Reporting Associated With Animal Drug and Animal Generic Drug User Fees", "Notice", "60 Day Proposed Information Collection", "2026-03-23", 2026, 3, "2026-03-23", "2026-05-23", "2026-03-23 17:37:47", "2026-05620", 1, 0, "09000064b922c25e"], ["FDA-2026-N-2364-0001", "FDA", "FDA-2026-N-2364", "Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug\nAdministration Advisory Committees", "Notice", "60 Day Proposed Information Collection", "2026-03-23", 2026, 3, "2026-03-23", "2026-05-23", "2026-03-25 09:00:29", "2026-05623", 1, 0, "09000064b922c187"], ["FDA-2026-N-1849-0001", "FDA", "FDA-2026-N-1849", "Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notifications Submission", "Notice", "60 Day Proposed Information Collection", "2026-03-19", 2026, 3, "2026-03-19", "2026-05-19", "2026-03-19 17:24:48", "2026-05329", 1, 0, "09000064b9224334"], ["FDA-2026-N-2279-0001", "FDA", "FDA-2026-N-2279", "Preparation for International Cooperation on Cosmetics Regulation Twentieth Annual Meeting (ICCR\u201320); Request for Comments", "Notice", "Request for Comments", "2026-03-18", 2026, 3, "2026-03-18", "2026-05-19", "2026-05-12 09:00:12", "2026-05280", 1, 0, "09000064b922165c"]], "truncated": false, "filtered_table_rows_count": 67, "expanded_columns": [], "expandable_columns": [], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 order by comment_end_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/open_comments/documents.json?agency_id=FDA&document_type=Notice", "results": [{"value": "FDA", "label": "FDA", "count": 67, "toggle_url": "https://pawtectors.org/open_comments/documents.json?document_type=Notice", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/open_comments/documents.json?agency_id=FDA&document_type=Notice", "results": [{"value": "Notice", "label": "Notice", "count": 67, "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=posted_date"}, {"name": "posted_year", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=posted_year"}, {"name": "posted_month", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=comment_end_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://pawtectors.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 10.87686000391841, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}